miR-223 is a coordinator of breast cancer progression as revealed by bioinformatics predictions

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Pinatel, Eva Maria ^a   Orso, Francesca ^a   Penna, Elisa ^a   Cimino, Daniela ^a   Elia, Angela Rita ^a   Circosta, Paola ^a   Dentelli, Patrizia ^b   Brizzi, Maria Felice ^b   Provero, Paolo ^a,c   Taverna, Daniela ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA3 INTEGRIN; DOXORUBICIN; MICRORNA 223; PACLITAXEL; PROTEIN NRAS; RAS PROTEIN; STAT5A PROTEIN; UNCLASSIFIED DRUG;

ALGORITHM; ANIMAL CELL; ANOIKIS; ARTICLE; BIOINFORMATICS; BREAST CANCER; CANCER GROWTH; CELL ADHESION; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG SENSITIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MATHEMATICAL COMPUTING; MOUSE; NONHUMAN; PREDICTION; TUMOR CELL;

3' UNTRANSLATED REGIONS; ANOIKIS; ANTINEOPLASTIC AGENTS; BASE PAIRING; BASE SEQUENCE; BREAST NEOPLASMS; CELL DEATH; CELL LINE, TUMOR; CELL MOVEMENT; COMPUTATIONAL BIOLOGY; DATABASES, FACTUAL; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; RNA PROCESSING, POST-TRANSCRIPTIONAL; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR;

EID: 84896467405     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084859     Document Type: Article

References (85)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
2. DeSantis C, Siegel R, Bandi P, Jemal A (2012) Breast cancer statistics, 2011. CA Cancer J Clin 61: 409-418.
3. Polyak K (2011) Heterogeneity in breast cancer. J Clin Invest 121: 3786-3788.
4. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536. (Pubitemid 34130608)
5. Perou CM (2011) Molecular stratification of triple-negative breast cancers. Oncologist 16 Suppl 1: 61-70.
6. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747-752.
7. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, et al. (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182. (Pubitemid 17231334)
8. Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, et al. (2008) Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 14: 518-527. (Pubitemid 351655218)
9. Ma XJ, Dahiya S, Richardson E, Erlander M, Sgroi DC (2009) Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res 11: R7.
10. DeNardo DG, Brennan DJ, Rexhepaj E, Ruffell B, Shiao SL, et al. (2011) Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov 1: 54-67.
11. Mahmoud SM, Paish EC, Powe DG, Macmillan RD, Grainge MJ, et al. (2011) Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. J Clin Oncol 29: 1949-1955.
12. Heys SD, Stewart KN, McKenzie EJ, Miller ID, Wong SY, et al. (2012) Characterisation of tumour-infiltrating macrophages: impact on response and survival in patients receiving primary chemotherapy for breast cancer. Breast Cancer Res Treat 135: 539-548.
13. Enerly E, Steinfeld I, Kleivi K, Leivonen SK, Aure MR, et al. (2011) miRNAmRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PLoS One 6: e16915.
14. Farazi TA, Horlings HM, Ten Hoeve JJ, Mihailovic A, Halfwerk H, et al. (2011) MicroRNA sequence and expression analysis in breast tumors by deep sequencing. Cancer Res 71: 4443-4453.
15. Rask L, Balslev E, Jorgensen S, Eriksen J, Flyger H, et al. (2011) High expression of miR-21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer. APMIS 119: 663-673.
16. Bronisz A, Godlewski J, Wallace JA, Merchant AS, Nowicki MO, et al. (2011) Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol 14: 159-167.
17. Yang M, Chen J, Su F, Yu B, Lin L, et al. (2011) Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer 10: 117.
18. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, et al. (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557-563. (Pubitemid 47525152)
19. Luga V, Zhang L, Viloria-Petit AM, Ogunjimi AA, Inanlou MR, et al. (2012) Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 151: 1542-1556.
20. Martins VR DM, Hainaut P (2013) Tumor-cell-derived microvesicles as carriers of molecular information in cancer. Current Opinion Oncology.
21. Pasquinelli AE (2012) MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet 13: 271-282.
22. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, et al. (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136. (Pubitemid 351485639)
23. Jiang S, Zhang HW, Lu MH, He XH, Li Y, et al. (2010) MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res 70: 3119-3127.
24. Ma L, Teruya-Feldstein J, Weinberg RA (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688. (Pubitemid 47552092)
25. Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, et al. (2008) The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 10: 202-210. (Pubitemid 351194050)
26. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, et al. (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451: 147-152.
27. Yu Z, Wang C, Wang M, Li Z, Casimiro MC, et al. (2008) A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol 182: 509-517.
28. Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, et al. (2009) Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138: 592-603.
29. Yu F, Yao H, Zhu P, Zhang X, Pan Q, et al. (2007) let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131: 1109-1123. (Pubitemid 350235025)
30. He L, He X, Lim LP, de Stanchina E, Xuan Z, et al. (2007) A microRNA component of the p53 tumour suppressor network. Nature 447: 1130-1134. (Pubitemid 47014436)
31. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, et al. (2009) A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137: 1032-1046.
32. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103: 2257-2261. (Pubitemid 43271657)
33. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838. (Pubitemid 40839735)
34. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, et al. (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-659. (Pubitemid 47214727)
35. Breakefield XO, Frederickson RM, Simpson RJ (2011) Gesicles: Microvesicle "cookies" for transient information transfer between cells. Mol Ther 19: 1574-1576.
36. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009. (Pubitemid 35461656)
37. Pawitan Y, Bjohle J, Amler L, Borg AL, Egyhazi S, et al. (2005) Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res 7: R953-964.
38. Miller LD, Smeds J, George J, Vega VB, Vergara L, et al. (2005) An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci U S A 102: 13550-13555. (Pubitemid 41420886)
39. Desmedt C, Piette F, Loi S, Wang Y, Lallemand F, et al. (2007) Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin Cancer Res 13: 3207-3214. (Pubitemid 46944903)
40. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, et al. (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31: e15.
41. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
42. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20. (Pubitemid 40094598)
43. Enright AJ, John B, Gaul U, Tuschl T, Sander C, et al. (2003) MicroRNA targets in Drosophila. Genome Biol 5: R1.
44. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140-144.
45. Kiriakidou M, Nelson PT, Kouranov A, Fitziev P, Bouyioukos C, et al. (2004) A combined computational-experimental approach predicts human microRNA targets. Genes Dev 18: 1165-1178. (Pubitemid 38669037)
46. Cimino D, De Pitta C, Orso F, Zampini M, Casara S, et al. (2013) miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1. FASEB J 27: 1223-1235.
47. Volinia S, Visone R, Galasso M, Rossi E, Croce CM (2009) Identification of microRNA activity by Targets' Reverse EXpression. Bioinformatics 26: 91-97.
48. Team RDC (2008) R: A language and enviroment for statistical computing. R foundation for statistical computing. Vienna, Austria. http://wwwr-projectorg ISBN 3-900051-07-0.
49. Wang Y, Liu X, Chen L, Cheng D, Rusckowski M, et al. (2009) Tumor delivery of antisense oligomer using trastuzumab within a streptavidin nanoparticle. Eur J Nucl Med Mol Imaging 36: 1977-1986.
50. DiPersio CM, Shah S, Hynes RO (1995) alpha 3A beta 1 integrin localizes to focal contacts in response to diverse extracellular matrix proteins. J Cell Sci 108 (Pt 6): 2321-2336.
51. Bookout AL, Mangelsdorf DJ (2003) Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways. Nucl Recept Signal 1: e012.
52. Orso F, Penna E, Cimino D, Astanina E, Maione F, et al. (2008) AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs. FASEB J 22: 2702-2714.
53. Penna E, Orso F, Cimino D, Tenaglia E, Lembo A, et al. (2011) microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. EMBO J 30: 1990-2007.
54. Kueng W, Silber E, Eppenberger U (1989) Quantification of cells cultured on 96-well plates. Anal Biochem 182: 16-19. (Pubitemid 19251274)
55. Rasola A, Geuna M (2001) A flow cytometry assay simultaneously detects independent apoptotic parameters. Cytometry 45: 151-157. (Pubitemid 32954245)
56. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, et al. (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99: 15524-15529. (Pubitemid 35403967)
57. Shirdel EA, Xie W, Mak TW, Jurisica I (2011) NAViGaTing the micronome-using multiple microRNA prediction databases to identify signalling pathway-associated microRNAs. PLoS One 6: e17429.
58. Mu P, Han YC, Betel D, Yao E, Squatrito M, et al. (2009) Genetic dissection of the miR-17-92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev 23: 2806-2811.
59. Fu X, Han Y, Wu Y, Zhu X, Lu X, et al. (2011) Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis. Eur J Clin Invest 41: 1245-1253.
60. Viticchie G, Lena AM, Latina A, Formosa A, Gregersen LH, et al. (2011) MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines. Cell Cycle 10: 1121-1131.
61. Agatheeswaran S, Singh S, Biswas S, Biswas G, Chandra Pattnayak N, et al. (2012) BCR-ABL mediated repression of miR-223 results in the activation of MEF2C and PTBP2 in chronic myeloid leukemia. Leukemia.
62. Wu ZS, Wu Q, Wang CQ, Wang XN, Huang J, et al. (2011) miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met. Cancer.
63. Volinia S, Galasso M, Sana ME, Wise TF, Palatini J, et al. (2012) Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. Proc Natl Acad Sci U S A 109: 3024-3029.
64. Dvinge H, Git A, Graf S, Salmon-Divon M, Curtis C, et al. (2013) The shaping and functional consequences of the microRNA landscape in breast cancer. Nature 497: 378-382.
65. Buffa FM, Camps C, Winchester L, Snell CE, Gee HE, et al. (2011) microRNAassociated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. Cancer Res 71: 5635-5645.
66. Re A, Cora D, Taverna D, Caselle M (2009) Genome-wide survey of microRNA-transcription factor feed-forward regulatory circuits in human. Mol Biosyst 5: 854-867.
67. Lim PK, Bliss SA, Patel SA, Taborga M, Dave MA, et al. (2011) Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Res 71: 1550-1560.
68. Jia CY, Li HH, Zhu XC, Dong YW, Fu D, et al. (2011) MiR-223 suppresses cell proliferation by targeting IGF-1R. PLoS One 6: e27008.
69. Wu L, Li H, Jia CY, Cheng W, Yu M, et al. (2012) MicroRNA-223 regulates FOXO1 expression and cell proliferation. FEBS Lett 586: 1038-1043.
70. Li S, Li Z, Guo F, Qin X, Liu B, et al. (2011) miR-223 regulates migration and invasion by targeting Artemin in human esophageal carcinoma. J Biomed Sci 18: 24.
71. Li X, Zhang Y, Zhang H, Liu X, Gong T, et al. (2011) miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res 9: 824-833.
72. Gong B, Hu H, Chen J, Cao S, Yu J, et al. (2013) Caprin-1 is a novel microRNA-223 target for regulating the proliferation and invasion of human breast cancer cells. Biomed Pharmacother.
73. Bhatnagar N, Li X, Padi SK, Zhang Q, Tang MS, et al. (2010) Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells. Cell Death Dis 1: e105.
74. Kopp F, Oak PS, Wagner E, Roidl A (2012) miR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expression. PLoS One 7: e50469.
75. Masciarelli S, Fontemaggi G, Di Agostino S, Donzelli S, Carcarino E, et al. (2013) Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells. Oncogene.
76. Yang T, Zheng ZM, Li XN, Li ZF, Wang Y, et al. (2013) MiR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells. Exp Biol Med (Maywood).
77. Subbaram S, Dipersio CM (2012) Integrin alpha3beta1 as a breast cancer target. Expert Opin Ther Targets 15: 1197-1210.
78. Baines AT, Xu D, Der CJ (2011) Inhibition of Ras for cancer treatment: the search continues. Future Med Chem 3: 1787-1808.
79. Ferbeyre G, Moriggl R (2010) The role of Stat5 transcription factors as tumor suppressors or oncogenes. Biochim Biophys Acta 1815: 104-114.
80. Dentelli P, Rosso A, Orso F, Olgasi C, Taverna D, et al. (2010) microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression. Arterioscler Thromb Vasc Biol 30: 1562-1568.
81. Furth PA, Nakles RE, Millman S, Diaz-Cruz ES, Cabrera MC (2011) Signal transducer and activator of transcription 5 as a key signaling pathway in normal mammary gland developmental biology and breast cancer. Breast Cancer Res 13: 220.
82. Shi Z, Hodges VM, Dunlop EA, Percy MJ, Maxwell AP, et al. (2012) Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line. Mol Cancer Res 8: 615-626.
83. Fox EM, Bernaciak TM, Wen J, Weaver AM, Shupnik MA, et al. (2008) Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells. Mol Endocrinol 22: 1781-1796.
84. Kosova B, Tezcanli B, Ekiz HA, Cakir Z, Selvi N, et al. (2010) Suppression of STAT5A increases chemotherapeutic sensitivity in imatinib-resistant and imatinib-sensitive K562 cells. Leuk Lymphoma 51: 1895-1901.
85. Purclutepe O, Iskender G, Kiper HD, Tezcanli B, Selvi N, et al. (2012) Enalapril-induced apoptosis of acute promyelocytic leukaemia cells involves STAT5A. Anticancer Res 32: 2885-2893.